These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 899724)

  • 1. The significance of atypical mitoses in malignant meningiomas.
    Fabiani A; Trebini F; Favero M; Peres B; Palmucci L
    Acta Neuropathol; 1977 Jun; 38(3):229-31. PubMed ID: 899724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological subtypes and prognostic problems in meningiomas.
    Jellinger K; Slowik F
    J Neurol; 1975; 208(4):279-98. PubMed ID: 50413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological features to define atypical meningioma: What does really matter for prognosis?
    Barresi V; Lionti S; Caliri S; Caffo M
    Brain Tumor Pathol; 2018 Jul; 35(3):168-180. PubMed ID: 29671247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications.
    Perry A; Jenkins RB; Dahl RJ; Moertel CA; Scheithauer BW
    Cancer; 1996 Jun; 77(12):2567-73. PubMed ID: 8640707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
    Perry A; Scheithauer BW; Stafford SL; Lohse CM; Wollan PC
    Cancer; 1999 May; 85(9):2046-56. PubMed ID: 10223247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical and malignant meningiomas: a clinicopathological review.
    Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
    Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.
    Maier H; Ofner D; Hittmair A; Kitz K; Budka H
    J Neurosurg; 1992 Oct; 77(4):616-23. PubMed ID: 1527622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical meningioma: morphometric analysis of nuclear pleomorphism].
    Pennella A; Ferri C; Lettini T; Serio G; Cimmino A; Caniglia DM; Giangaspero F; Ricco R
    Pathologica; 2000 Feb; 92(1):25-31. PubMed ID: 10842997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features.
    Alvarez F; Roda JM; Pérez Romero M; Morales C; Sarmiento MA; Blázquez MG
    Neurosurgery; 1987 May; 20(5):688-94. PubMed ID: 3601014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.
    Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P
    Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of aggressive meningiomas.
    Drape JL; Krause D; Tongio J
    J Neuroradiol; 1992; 19(1):49-62. PubMed ID: 1564530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior?
    Kepes JJ
    J Neuropathol Exp Neurol; 1986 Mar; 45(2):95-107. PubMed ID: 3005518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
    Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
    Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
    Palma L; Celli P; Franco C; Cervoni L; Cantore G
    J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in anterior skull base meningiomas.
    Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas.
    Kim MS; Kim KH; Lee EH; Lee YM; Lee SH; Kim HD; Kim YZ
    J Neurosurg; 2014 Nov; 121(5):1189-200. PubMed ID: 25148008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
    Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
    Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.